Omega-3 Fatty Acids
The polyunsaturated fatty acids EPA and DHA have one of the strongest evidence bases among cardiometabolic supplements — but the effect depends heavily on baseline blood levels, not just the dose on the label.
Number of studies
1
Safety
Moderate
Time to effects
A drop in triglycerides is usually visible after 4–8 weeks of regular supplementation.
Who it's for
Table of contents
TL;DR
The polyunsaturated fatty acids EPA and DHA have one of the strongest evidence bases among cardiometabolic supplements — but the effect depends heavily on baseline blood levels, not just the dose on the label.
- →Lowers triglyceride levels, especially when baseline levels are elevated
- →Supports cardiovascular health as part of an overall eating pattern
- →DHA is an important structural component of neuronal and retinal membranes
| Compound type | Long-chain polyunsaturated fatty acids (EPA, DHA) |
|---|---|
| Level of evidence | Strong — decades of research into effects on cardiovascular health |
| Target group | People who rarely eat fatty saltwater fish, people with elevated triglycerides |
| Typical dose | 250–1000 mg EPA+DHA daily for general prevention; higher for elevated triglycerides |
| Interactions | Can enhance the effect of anticoagulant medications at high doses |
| Status | An over-the-counter dietary supplement; high doses are also available as a prescription drug |
Understand
Overview
Omega-3 fatty acids, above all EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are long-chain polyunsaturated fatty acids found mainly in fatty saltwater fish and marine algae, which the body cannot synthesize in sufficient amounts on its own. The meta-analysis by Mozaffarian and Wu, one of the most frequently cited in this area, summarized decades of research into their relationship with cardiovascular risk.
It's worth emphasizing that the effect of omega-3 supplementation depends heavily on baseline levels of these fatty acids in the blood (the so-called omega-3 index) — people with low fish intake and an already low baseline level derive a much clearer benefit than people who already regularly eat fatty fish. This partly explains the mixed results of large clinical trials, in which part of the population already had adequate intake.
Who can genuinely benefit from this? People who rarely eat fatty saltwater fish (salmon, mackerel, sardines), as well as people with elevated triglycerides, in whom higher doses of EPA/DHA have a documented triglyceride-lowering effect. People who regularly eat fatty fish several times a week may not gain additional benefit from supplementation beyond what their diet already provides.
Mechanism of action
EPA and DHA incorporate into cell membranes, including those of cardiomyocytes and neurons, changing their fluidity and affecting cell signaling. EPA is additionally a precursor of anti-inflammatory eicosanoids, competing with arachidonic acid (derived from omega-6) for the same enzymes, which, given sufficient intake, shifts the balance toward less pro-inflammatory mediators.
In the cardiovascular context, omega-3s lower triglyceride levels by limiting their production in the liver, can slightly lower blood pressure, and show an antithrombotic effect by influencing platelet aggregation. DHA is also an important structural component of neuronal and retinal membranes, which explains the research interest in its role in the development and functioning of the nervous system.
Incorporation into cell membranes
EPA and DHA change the fluidity of cell membranes, including those of cardiomyocytes and neurons.
Competition with arachidonic acid
EPA competes for the same enzymes as omega-6, shifting the balance toward anti-inflammatory mediators.
Reduced triglyceride production
Omega-3s limit hepatic triglyceride production, lowering their blood levels.
Evidence: strong — based on 1 study in this database.
Benefits
Common myths
MythEvery omega-3 supplement works the same, regardless of EPA and DHA content.
FactEffectiveness depends on the actual EPA and DHA content, not the total amount of fish oil — it's worth checking the exact doses of these two acids on the label, not just the total weight of the capsule.
MythOmega-3 supplementation provides the same benefit regardless of diet.
FactPeople who already regularly eat fatty fish and have a high baseline omega-3 level in their blood derive a much smaller additional benefit from supplementation than people with low intake.
Forms & variants
Omega-3 Fatty Acids comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Fish oil
The most common source of EPA and DHA.
Best for: Standard supplementation
Algae oil
A plant-based source of DHA (and sometimes EPA), without a fishy aftertaste.
Best for: Vegans and people avoiding fish products
Practice
Frequently asked questions
Both forms provide bioavailable DHA, though algae oil usually contains less or no EPA — worth taking into account when choosing a product, especially if the goal is lowering triglycerides.
Eating fatty saltwater fish 2–3 times a week usually provides enough EPA and DHA without the need for additional supplementation.
Therapeutic doses (2–4 g daily) used for elevated triglycerides are usually safe, but carry a slightly higher bleeding risk, so it's worth using them under a doctor's supervision.
Dosage & timing
Typical dose
250–500 mg EPA+DHA daily for general prevention; 2–4 g daily for therapeutic triglyceride lowering under a doctor's supervision
Form
Fish oil, krill oil, or algae oil (for vegans), in capsules or liquid form
It's worth choosing products with clearly stated EPA and DHA content, not just the total amount of 'fish oil.'
Best times to take it
- Taking it with a meal containing fat improves absorption
What to combine with
Good combinations
Lipid Panel — It's worth monitoring the effect of omega-3 supplementation on triglycerides with a regular lipid panel
Safety
Side effects & contraindications
Possible side effects
Fishy aftertaste and burping with some preparations
Possible gastrointestinal discomfort at high doses
Contraindications
Blood clotting disorders — caution at high doses
Planned surgery — worth discontinuing a few days beforehand
Interactions
Anticoagulant medications (warfarin) — possible increased bleeding risk at high omega-3 doses
Is it worth taking?
Who it's for
- People who rarely eat fatty saltwater fish
- People with elevated triglycerides
Not for
- Blood clotting disorders — caution at high doses
- Planned surgery — worth discontinuing a few days beforehand
Evidence
Worth knowing
The omega-3 index (the level of EPA+DHA in red blood cell membranes) is an increasingly used marker for assessing the actual status of these fatty acids in the body.
EPA and DHA are the only fatty acids for which EFSA has approved an official health claim regarding maintaining normal heart function.
Studies
Available evidence consistently links higher omega-3 intake with a favorable lipid profile and lower cardiovascular risk, though the size of the effect depends significantly on baseline levels of these fatty acids in the body.
Mozaffarian D, Wu JHY, Journal of the American College of Cardiology, 2011
Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events
Strong evidenceMozaffarian D, Wu JHY · Journal of the American College of Cardiology · 2011
An extensive review of the mechanisms and clinical evidence regarding the effect of omega-3 fatty acids on cardiovascular risk factors and events.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Medical review
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
50 publications on this site
Related entries
4.6Lipid Panel
The lipid panel is one of the most important — and still one of the most frequently misread — preventive blood tests: 'total cholesterol' alone tells you less than the ratios between its fractions.
4.4Statins
The best-researched class of LDL-cholesterol-lowering drugs, with one of the largest evidence bases in all of cardiology — yet still surrounded by numerous, largely unfounded fears.
4.9Mediterranean Diet
The best-studied eating pattern for cardiovascular health and longevity.
4.7Sauna (Thermal Heat Therapy)
Regular sauna use is linked in cohort studies to lower cardiovascular mortality risk — the strongest data comes from Finland.
4.7Hypertension
The 'silent killer' — it runs symptom-free for years, yet it's one of the strongest, and largely modifiable, risk factors for stroke and heart attack in the world.
4.7TRT and Your Heart — Does Testosterone Therapy Raise Heart Attack Risk?
For a decade, testosterone therapy operated under the shadow of an FDA warning about heart attack risk. The large randomized TRAVERSE trial from 2023 finally gave a clear answer — though not as simple as the headlines suggested. We walk through the whole story, from controversial observational studies to where the evidence stands today.
4.6Coronary Artery Calcium (CAC)
A non-invasive CT scan that directly measures the amount of calcification in the coronary arteries — one of the strongest available predictors of a future heart attack in people without symptoms.
4.5CRP and hs-CRP
A protein produced by the liver in response to inflammation — in its high-sensitivity form (hs-CRP) it has become one of the most widely studied additional markers of cardiovascular risk.
Related articles
Badania naukoweLongevity Vitamins: Which Supplements Actually Have Real Scientific Evidence Behind Them
Every supplement shelf promises a longer life in every capsule, but the hard data from large clinical trials tells a far more measured story. We go through which vitamins genuinely extend healthy lifespan in people with a real deficiency, and which — despite their popularity — have no supporting evidence at all, or worse, evidence of no benefit.
August 20, 2026
PoradnikiHow to read supplement labels so you don't get fooled — a guide
What's stated on a supplement label doesn't always match what's actually inside the capsule. Here's a practical guide to what to look out for before you buy.
August 11, 2026
PoradnikiOmega-3 Fatty Acids and Depression: Why Do Form and Dose Determine Effectiveness?
"Omega-3 for depression" is one of those recommendations heard so often that almost no one asks about the details — and in this case, the details decide everything. Two independent meta-analyses consistently show that the antidepressant effect isn't a property of "omega-3 fatty acids" as a whole, but of a specific fatty acid, EPA, within a specific, moderate dose range — and exceeding that range paradoxically weakens the effect instead of strengthening it.
August 25, 2026
PoradnikiHigh-Dose Omega-3 and Atrial Fibrillation: An Unexpected Side Effect?
Omega-3 fatty acids have a well-established reputation as an unambiguously heart-healthy supplement. Two independent, large clinical trials evaluating high, prescription-strength omega-3 doses (4g/day) in cardiac patients show a consistent and concerning signal: this therapy meaningfully increases the risk of new-onset atrial fibrillation — an irregular heart rhythm — even in a trial where the same supplement produced a real, measurable cardiovascular benefit. This is not a warning about a typical over-the-counter fish oil supplement, but a specific signal tied to the high doses used to treat hypertriglyceridemia — a distinction that's easy to lose in simplified headlines.
August 25, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.